Market Research Future Published a Half Cooked Research Report on Global Breast imaging Market. Breast Imaging: Rising demand for diagnostic tools for cancer drives the growth of the Global Market
Breast imaging is used for diagnosis of breast cancer in women. It is also used to determine the risk of breast cancer among women. Early detection of the disease helps healthcare providers to decide the line of treatment talking into account the severity of the disease. Various imaging test used for the diagnosis of breast cancer are mammography, ultrasound, CT, PET, MRI and many more.
The global breast imaging market is determined by an increasing demand for innovative diagnostic devices by healthcare professionals, increasing awareness about women health and increasing prevalence of breast cancer. However, high cost of breast imaging devices is a major restrain for the market growth.
The Global Breast Imaging Market is expected to grow at a CAGR of 8.5% during the forecast period.
Taste the market data and market information presented through more than 120 market data tables and figures spread over 200 pages of the project report. Avail the in-depth table of content (TOC) & market synopsis on “Breast Imaging market research report–Global forecast till 2023.”
Get a sample report at https://www.marketresearchfuture.com/sample_request/5612 .
Major Players in Breast Imaging Market:
Some of the key players in the global market are General Electric Company (U.K.), Siemens (Germany), Koninklijke Philips N.V. (Netherlands), Hologic, Inc. (U.S.), Fujifilm Holdings Corporation (Japan), Dilon Technologies, Inc. (U.S.), Aurora Imaging Technology, Inc. (U.S.), Gamma Medica, Inc. (U.S.), Toshiba Corporation (Japan), Sonocine, Inc. (U.S.) and others.
The American market for breast imaging is boosted by changing lifestyle of women, rising prevalence of breast cancer, and presence of major players in the market. In the U.S., extensive use of imaging devices for cancer diagnosis is the major factor for the market growth. While Canada is the second largest market in North America. South American market is expected to exhibit a positive growth owing to an increase in the demand for new imaging devices and treatment options for cancer.
The European market is ruled by research and development in oncology and increasing number of market players manufacturing imaging devices. Furthermore, well developed healthcare infrastructure and rising government support for research in cancer diagnostics fuel the market growth. In Germany, the market growth is fuelled by increasing use of medical devices for the diagnosis of chronic diseases and focus on cancer management in hospitals and research institutes. France is the second largest market followed by U.K.
The breast imaging market in Asia Pacific is expected to show the fastest growth with rapid development of medical devices sector, increasing healthcare expenditure and focus on women healthcare. Furthermore, the increasing government initiatives such as healthcare programs for women, awareness drives about breast cancer, and its diagnosis also boost the market during the review period.
The Middle East & Africa breast imaging market demonstrates steady growth in the market with an increasing availability of essential diagnostic imaging devices and increasing use of modern imaging technologies for cancer diagnosis and screening.
Browse complete report at https://www.marketresearchfuture.com/reports/breast-imaging-market-5612 .
The global breast imaging market is segmented on the basis of type, deployment, application, and end user.
On the basis of type, market is segmented into mammography, CT, PET, MRI, ultrasound, breast biopsy, tactile imaging and others
Mammography is further segmented into film-screen mammography, Full-field digital mammography (FFDM), 3D mammography, scintimammography or molecular breast imaging, and others.
Breast biopsy is further segmented into image-guided breast biopsy, tactic core biopsy, ultrasound-guided core biopsy and others.
On the basis of application, the market is segmented into breast cancer diagnosis, post-neoadjuvant chemotherapy, metastatic axillary adenocarcinoma, and others.
On the basis of end user, the market is segmented into hospitals, diagnostic centers and others.
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Market Research Future
P: +1 646 845 9312